Digirad Introduces nSPEED(SM) - The New Standard In Cardiac SPECT Reconstruction
June 04 2007 - 7:00AM
PR Newswire (US)
POWAY, Calif., June 4 /PRNewswire-FirstCall/ -- Digirad Corporation
(NASDAQ:DRAD) demonstrates its commitment to clinical excellence
and technological advancement by introducing nSPEED, an advanced
three dimensional SPECT image reconstruction technique. This
advanced algorithm provides the clinicians with significant image
quality improvement over existing 2D reconstruction techniques by
producing clearer and more accurate images to help improve
physicians' interpretation confidence. nSPEED models the
depth-dependent point response function in an iterative
reconstruction algorithm (OSEM), thus enabling depth-dependent
resolution recovery and improving chamber contrast in cardiac SPECT
images. Such improvement may further enable the reduction of
acquisition time while maintaining image quality as compared to
conventional reconstruction without depth-dependent resolution
recovery, while adhering to ASNC imaging guidelines. With this
product, Digirad is striving to obtain ASNC and other society
acceptance in order to meet accreditation requirements. Preliminary
studies of nSPEED have resulted in equivalent diagnostic quality
for stress and rest images with reliable function quantitation
measurements from gated stress images and reliable quantitation of
perfusion defect severity on stress and rest images. "Our next step
is to conduct multi-center study that will seek to demonstrate that
nSPEED offers the opportunity to cut the acquisition time for
cardiac SPECT studies in half while maintaining equivalent or
better clinical results than those produced by 2D reconstruction
techniques," said Mark Casner, President and CEO, Digirad. "We
believe that with nSPEED, Digirad's Cardius(R) 3 XPO triple-head
cameras will be able to perform a four minute rest study and a
three minute stress study, increasing throughput and decreasing
patient motion and patient imaging time." About Digirad Digirad
Corporation provides diagnostic imaging products and services to
physicians' offices, hospitals and other medical providers for use
in cardiology, internal medicine, and general imaging applications.
Digirad designed and commercialized the first solid-state nuclear
gamma camera for the detection of cardiovascular disease and other
medical conditions. The unique lightweight and compact design of
Digirad's cameras allows use in small office spaces and for mobile
services. For more information, go to http://www.digirad.com/.
Digirad(R) is a registered trademark of Digirad Corporation.
Forward Looking Statements Digirad cautions that statements
included in this press release that are not a description of
historical facts are forward looking statements. You can identify
these statements by the fact that they do not relate strictly to
historical or current facts and use words such as "anticipate,"
"estimate," "expect," "project," "intend," "plan," "believe" and
other words and terms of similar meaning in connection with a
discussion of future operating or financial performance or events.
Examples of such statements include the statements concerning the
performance and image quality improvements we expect to obtain
through nSPEED. The inclusion of these and other forward looking
statements should not be regarded as a representation by Digirad
that any of its plans will be achieved. Actual results may differ
materially from those set forth in this press release due to the
risks and uncertainties inherent in Digirad's business including,
without limitation: Digirad's ability to develop and market nSPEED
as planned, and the degree to which Digirad's nSPEED will be
accepted by physicians and hospitals; and other risks detailed in
Digirad's Annual Report on Form 10-K and other reports filed with
the U.S. Securities and Exchange Commission. DATASOURCE: Digirad
Corporation CONTACT: Dan Matsui, investors, or Len Hall, media,
+1-949-474-4300, both of Allen & Caron for Digirad Corporation;
or Randy Weatherhead, Sr. V.P., Sales & Marketing of Digirad
Corporation, +1-858-726-1633 Web site: http://www.digirad.com/
Copyright
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Jul 2023 to Jul 2024